BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22928592)

  • 1. Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis.
    Maugeri N; Franchini S; Campana L; Baldini M; Ramirez GA; Sabbadini MG; Rovere-Querini P; Manfredi AA
    Autoimmunity; 2012 Dec; 45(8):584-7. PubMed ID: 22928592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress elicits platelet/leukocyte inflammatory interactions via HMGB1: a candidate for microvessel injury in sytemic sclerosis.
    Maugeri N; Rovere-Querini P; Baldini M; Baldissera E; Sabbadini MG; Bianchi ME; Manfredi AA
    Antioxid Redox Signal; 2014 Mar; 20(7):1060-74. PubMed ID: 24070090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet microparticles sustain autophagy-associated activation of neutrophils in systemic sclerosis.
    Maugeri N; Capobianco A; Rovere-Querini P; Ramirez GA; Tombetti E; Valle PD; Monno A; D'Alberti V; Gasparri AM; Franchini S; D'Angelo A; Bianchi ME; Manfredi AA
    Sci Transl Med; 2018 Jul; 10(451):. PubMed ID: 30045975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis.
    Iversen LV; Østergaard O; Ullman S; Nielsen CT; Halberg P; Karlsmark T; Heegaard NH; Jacobsen S
    Scand J Rheumatol; 2013; 42(6):473-82. PubMed ID: 24016306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet Phagocytosis via P-selectin Glycoprotein Ligand 1 and Accumulation of Microparticles in Systemic Sclerosis.
    Manfredi AA; Ramirez GA; Godino C; Capobianco A; Monno A; Franchini S; Tombetti E; Corradetti S; Distler JHW; Bianchi ME; Rovere-Querini P; Maugeri N
    Arthritis Rheumatol; 2022 Feb; 74(2):318-328. PubMed ID: 34279048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis.
    Guiducci S; Distler JH; Jüngel A; Huscher D; Huber LC; Michel BA; Gay RE; Pisetsky DS; Gay S; Matucci-Cerinic M; Distler O
    Arthritis Rheum; 2008 Sep; 58(9):2845-53. PubMed ID: 18759303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased circulating concentrations of the counteradhesive proteins SPARC and thrombospondin-1 in systemic sclerosis (scleroderma). Relationship to platelet and endothelial cell activation.
    Macko RF; Gelber AC; Young BA; Lowitt MH; White B; Wigley FM; Goldblum SE
    J Rheumatol; 2002 Dec; 29(12):2565-70. PubMed ID: 12465153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in platelet non-integrin type I collagen receptor in patients with systemic sclerosis.
    Chiang TM; Takayama H; Postlethwaite AE
    Thromb Res; 2006; 117(3):299-306. PubMed ID: 16378833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis.
    Solanilla A; Villeneuve J; Auguste P; Hugues M; Alioum A; Lepreux S; Ducroix JP; Duhaut P; Conri C; Viallard JF; Nurden AT; Constans J; Ripoche J
    Rheumatology (Oxford); 2009 Sep; 48(9):1036-44. PubMed ID: 19549789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-derived microparticles during and after acute coronary syndrome.
    Skeppholm M; Mobarrez F; Malmqvist K; Wallén H
    Thromb Haemost; 2012 Jun; 107(6):1122-9. PubMed ID: 22371053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased circulating platelet-leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study.
    Pamuk GE; Turgut B; Pamuk ON; Vural O; Demir M; Cakir N
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):297-302. PubMed ID: 17473568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Behçet's disease.
    Macey M; Hagi-Pavli E; Stewart J; Wallace GR; Stanford M; Shirlaw P; Fortune F
    Rheumatology (Oxford); 2011 Oct; 50(10):1849-59. PubMed ID: 21719422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-derived HMGB1 is a critical mediator of thrombosis.
    Vogel S; Bodenstein R; Chen Q; Feil S; Feil R; Rheinlaender J; Schäffer TE; Bohn E; Frick JS; Borst O; Münzer P; Walker B; Markel J; Csanyi G; Pagano PJ; Loughran P; Jessup ME; Watkins SC; Bullock GC; Sperry JL; Zuckerbraun BS; Billiar TR; Lotze MT; Gawaz M; Neal MD
    J Clin Invest; 2015 Dec; 125(12):4638-54. PubMed ID: 26551681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of soluble P-selectin by platelets and endothelial cells.
    Semenov AV; Romanov YA; Loktionova SA; Tikhomirov OY; Khachikian MV; Vasil'ev SA; Mazurov AV
    Biochemistry (Mosc); 1999 Nov; 64(11):1326-35. PubMed ID: 10611541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of angiogenesis by platelets in systemic sclerosis patients.
    Hirigoyen D; Burgos PI; Mezzano V; Duran J; Barrientos M; Saez CG; Panes O; Mezzano D; Iruretagoyena M
    Arthritis Res Ther; 2015 Nov; 17():332. PubMed ID: 26584613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of changes in circulating platelet-derived microparticles and platelet surface P-selectin expression after coronary stent implantation.
    Inoue T; Hikichi Y; Morooka T; Yoshida K; Fujimatsu D; Komoda H; Kameda M; Nonaka M; Sohma R; Hashimoto S; Node K
    Platelets; 2006 Sep; 17(6):416-20. PubMed ID: 16973503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-sectional study of soluble selectins, fractions of circulating microparticles and their relationship to lung and skin involvement in systemic sclerosis.
    Iversen LV; Ullman S; Østergaard O; Nielsen CT; Halberg P; Karlsmark T; Heegaard NH; Jacobsen S
    BMC Musculoskelet Disord; 2015 Aug; 16():191. PubMed ID: 26265409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The origin of P-selectin as a circulating plasma protein.
    Fijnheer R; Frijns CJ; Korteweg J; Rommes H; Peters JH; Sixma JJ; Nieuwenhuis HK
    Thromb Haemost; 1997 Jun; 77(6):1081-5. PubMed ID: 9241736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelets are relevant mediators of renal injury induced by primary endothelial lesions.
    Schwarzenberger C; Sradnick J; Lerea KM; Goligorsky MS; Nieswandt B; Hugo CP; Hohenstein B
    Am J Physiol Renal Physiol; 2015 Jun; 308(11):F1238-46. PubMed ID: 25834071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric detection of activated platelets: comparison of determining shape change, fibrinogen binding, and P-selectin expression.
    Ruf A; Patscheke H
    Semin Thromb Hemost; 1995; 21(2):146-51. PubMed ID: 7544916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.